Friday, August 8, 2025 8/8/2025

Centers for AIDS Research (CFAR)

Award Number: P30AI064518
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/01/2005
PERIOD OF PERFORMANCE END DATE: 06/30/2025

Group Awards By:

View Award Description

Centers for AIDS Research (CFAR) - PROJECT SUMMARY – Duke Center for AIDS Research (Overall) The principal mission of the Duke Center for AIDS Research (CFAR) is to establish and grow comprehensive infrastructure support for a research environment that will effectively promote collaboration, coordination, and innovation throughout the Duke HIV/AIDS research community and across the national CFAR network. As evidenced by the growth in our NIH-Funded Research Base that now qualifies us as a Tier 2 CFAR, this competitive renewal application represents an evolution that builds upon our accomplishments and lessons learned during the previous funding cycles, taking advantage of the synergies established among our Core components. A solid basis is formed by our highly successful Pilot Grant mechanism, aimed primarily at Early Stage Investigators, and our equally successful faculty recruitment efforts, both of which have facilitated greater gender and racial diversity. The driving force behind all of our evolving support services is a highly active and effective Strategic Planning process, led by our Executive Committee (EC), with valuable input from both our advisory committees and our intramural Strategic Partners. This highly iterative process has identified five Specific Aims to guide the CFAR's growth and evolution over the next 5 years: 1) Provide comprehensive infrastructure support to all intramural HIV/AIDS investigators aimed at expanding the robust program of inter- disciplinary, collaborative HIV research that addresses NIH Research priorities. 2) Continue development of a pipeline of next generation HIV/AIDS investigators through strong support of Early Stage Investigators and engagement of established investigators from outside the field of HIV/AIDS research. 3) Foster critical synergies through Core-Core interactions and engagement of new and existing Strategic Partnerships. 4) Expand the relevance, reach, and impact of HIV/AIDS research by implementing and supporting community engagement and outreach. 5) Further enhance and support collaborative activities throughout the global network of CFARs. Support services will be enhanced by increased institutional support from Duke's School of Medicine and Department of Surgery. Through our Strategic Planning process, we have identified eight priority areas that represent opportunities for further development during the next funding cycle. These include: 1) the `Southern HIV Epidemic'; 2) HIV Co-Morbidities, Co-Infections, and Complications; 3) Latency and Eradication; 4) Health Disparities; 5) Vaccine Design and Evaluation; 6) Mental Health and Substance Abuse; 7) the HIV Organ Policy Equity (HOPE) Act; and 8) Emerging Infections. Finally, to ensure the continued high-quality support for intramural HIV/AIDS investigators, the EC has formulated a Leadership Transition Plan, vetted by the institution, in which Dr. Georgia Tomaras and Dr. Susanna Naggie will become Director and Co-Director, respectively. The CFAR looks forward to developing and exploring these timely opportunities within Duke and across the CFAR network throughout the next funding cycle.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	000	20	12/11/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $2,722,365 )
2024	2024	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	002	20	7/1/2024	NON-COMPETING CONTINUATION	$2,250,000
2024	2024	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	003	20	7/2/2024	SUPPLEMENT FOR EXPANSION	$472,365
2024	2023	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	001	19	5/24/2024	SUPPLEMENT FOR EXPANSION	$0
2024	2023	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	000	19	1/4/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,722,365

Issue Date FY: 2023 ( Subtotal = $3,305,611 )
2023	2023	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	001	19	8/23/2023	NON-COMPETING CONTINUATION	$402,147
2023	2023	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	002	19	8/23/2023	SUPPLEMENT FOR EXPANSION	$506,691
2023	2023	DUKE UNIVERSITY	2200 W MAIN ST	DURHAM	NC	27705	DURHAM	USA	Allergy and Infectious Diseases Research	000	19	8/18/2023	NON-COMPETING CONTINUATION	$2,396,773
														Subtotal = $3,305,611

Issue Date FY: 2022 ( Subtotal = $2,688,655 )
2022	2022	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	002	18	8/15/2022	NON-COMPETING CONTINUATION	$438,655
2022	2022	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	18	7/29/2022	NON-COMPETING CONTINUATION	$2,250,000
2022	2021	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	17	2/1/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $2,688,655

Issue Date FY: 2021 ( Subtotal = $3,301,919 )
2021	2021	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	003	17	9/15/2021	NON-COMPETING CONTINUATION	$1,051,919
2021	2021	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	17	8/11/2021	NON-COMPETING CONTINUATION	$2,250,000
2021	2020	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	002	16	9/8/2021	COMPETING CONTINUATION	$823,370
2021	2019	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	15	9/8/2021	NON-COMPETING CONTINUATION	-$823,370
														Subtotal = $3,301,919

Issue Date FY: 2020 ( Subtotal = $2,566,369 )
2020	2020	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	16	5/14/2020	COMPETING CONTINUATION	$0
2020	2020	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	16	5/13/2020	COMPETING CONTINUATION	$2,107,142
2020	2020	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	003	16	8/28/2020	COMPETING CONTINUATION	$316,369
2020	2020	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	002	16	7/17/2020	COMPETING CONTINUATION	$142,858
														Subtotal = $2,566,369

Issue Date FY: 2019 ( Subtotal = $1,979,638 )
2019	2019	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	003	15	6/27/2019	NON-COMPETING CONTINUATION	$1,648,981
2019	2019	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	005	15	9/4/2019	NON-COMPETING CONTINUATION	$330,657
2019	2019	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	006	15	9/5/2019	NON-COMPETING CONTINUATION	$0
2019	2019	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	004	15	7/19/2019	NON-COMPETING CONTINUATION	$0
2019	2018	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	14	4/22/2019	NON-COMPETING CONTINUATION	$0
2019	2018	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	002	14	6/5/2019	NON-COMPETING CONTINUATION	$0
2019	2018	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	14	4/12/2019	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,979,638

Issue Date FY: 2018 ( Subtotal = $1,831,319 )
2018	2018	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	002	14	8/31/2018	NON-COMPETING CONTINUATION	$0
2018	2018	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	14	6/27/2018	NON-COMPETING CONTINUATION	$1,648,981
2018	2018	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	14	8/29/2018	NON-COMPETING CONTINUATION	$182,338
														Subtotal = $1,831,319

Issue Date FY: 2017 ( Subtotal = $2,733,379 )
2017	2017	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	13	8/24/2017	NON-COMPETING CONTINUATION	$1,084,398
2017	2017	DUKE UNIVERSITY	2200 W MAIN ST STE 710	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	13	7/19/2017	NON-COMPETING CONTINUATION	$1,648,981
														Subtotal = $2,733,379

Issue Date FY: 2016 ( Subtotal = $1,938,987 )
2016	2016	DUKE UNIVERSITY	BOX 104004	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	12	7/20/2016	NON-COMPETING CONTINUATION	$1,648,981
2016	2016	DUKE UNIVERSITY	BOX 104004	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	12	8/18/2016	NON-COMPETING CONTINUATION	$290,006
														Subtotal = $1,938,987

Issue Date FY: 2015 ( Subtotal = $1,652,403 )
2015	2015	DUKE UNIVERSITY	BOX 104004	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	11	9/3/2015	COMPETING CONTINUATION	$278,869
2015	2015	DUKE UNIVERSITY	BOX 104004	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	11	5/5/2015	COMPETING CONTINUATION	$1,373,534
														Subtotal = $1,652,403

Issue Date FY: 2014 ( Subtotal = $1,645,710 )
2014	2014	DUKE UNIVERSITY	BOX 104004	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	000	10	6/20/2014	NON-COMPETING CONTINUATION	$1,645,710
														Subtotal = $1,645,710

Issue Date FY: 2013 ( Subtotal = $1,896,452 ) (Continued on the next page)
2013	2013	DUKE UNIVERSITY	BOX 104004	DURHAM	NC	27708	DURHAM	USA	Allergy and Infectious Diseases Research	001	8	3/11/2013	SUPPLEMENT FOR EXPANSION	$0
Grand Total All Awards = $41,843,240

Page 1 of 2 (84 items)12

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Centers for AIDS Research (CFAR)

Award Number: P30AI064518

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/01/2005

PERIOD OF PERFORMANCE END DATE: 06/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer